Evidence map›Paper›PMID 24522342›Full record

ArticleJournal of human hypertension2014

Role of leptin receptor gene polymorphisms in susceptibility to the development of essential hypertension: a case-control association study in a Northern Han Chinese population.

Y Liu, Y Q Lou, K Liu, J L Liu, Z G Wang, J Wen, Q Zhao, S J Wen, L Xiao

Open access · hybridAbstract read
In one paragraph

Article in Journal of human hypertension, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Leptin receptor gene polymorphisms and risk of hypertension: a meta-analysis.International journal of clinical and experimental medicine · 2015
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Y LiuDepartment of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, PR China.
Y Q Lou1] Department of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, PR China [2] Department of Pulmonary Disease, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, PR China.
K LiuEmergency Department, China MeiTan General Hospital, National Mining Medical Center, Beijing, PR China.
J L LiuDepartment of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, PR China.
Z G WangDepartment of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, PR China.
J WenDepartment of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, PR China.
Q Zhao1] Department of Medicine, Division of Cardiology, Northwestern University, Chicago, IL, USA [2] Department of Medicine & Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL, USA.
S J WenDepartment of Hypertension Research, Beijing Anzhen Hospital, Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, PR China.
L XiaoDepartment of Medicine & Center for Cardiovascular Research, University of Illinois at Chicago, Chicago, IL, USA.
Beijing Anzhen Hospital · CNCapital Medical University · CNMeitan General Hospital · CNNorthwestern University · USUniversity of Illinois Chicago · US

Funding

Role of p67phox in myocardial hypertrophyR01HL083218 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHAO, QIONG · 2008 to 2013
$2.0M
NHLBI NIH HHS 1R01-HL083218NHLBI NIH HHS 3R01-HL083218-01A2S1NHLBI NIH HHS R01 HL083218
6 · The paper itself

Abstract

In order to explore the potential association between the leptin receptor (LEPR) gene polymorphisms and essential hypertension (EH) risk in the Northern Han Chinese population, we recruited 823 hypertensive subjects and 491 healthy control subjects from the Northern Han Chinese. Genotyping was performed to identify the Lys109Arg, Gln223Arg and Lys656Asn polymorphisms of the LEPR gene. Significant associations were found in a dominant genetic model ([GG+AG] vs. AA), P=0.007, odds ratio (OR)=3.697, 95% confidence interval (CI) 1.442-9.482), and in homozygote comparison (GG vs. AA, P=0.005, OR=3.890, 95% CI 1.501-10.077) for the Gln223Arg polymorphism. No significant association could be found between Lys109Arg or Lys656Asn polymorphism and EH risk. Linkage disequilibrium was detected between the Lys109Arg and Gln223Arg polymorphisms, and haplotype analyses identified that the G-A haplotype was a protective haplotype for EH. Our studies demonstrated that the LEPR Gln223Arg polymorphism had an important role in a patient's susceptibility to EH in the Northern Han Chinese population.

Indexed as

Polymorphism, GeneticAdultAsian PeopleBlood PressureCase-Control StudiesChinaChi-Square DistributionFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHaplotypesHumansHypertensionLinkage DisequilibriumLogistic ModelsMaleLEPR protein, humanReceptors, Leptin

Identifiers

PMID24522342
PMCPMC4133281
OpenAlexW2044377048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.